Alebund Pharmaceuticals
Latest round
- Series C
Last raised
- Jan 2025
Total raised
- $190M
Investors
- 15
About Alebund Pharmaceuticals
Established in 2018 and based in Shanghai, China, Alebund Pharmaceuticals is a biopharmaceutical company that engages in the research and development of drugs for kidney diseases and related chronic diseases. The company's co-founder and CEO, Gavin Xia, received a PhD from the University of Chicago and has more than 15 years of experience in drug development in the healthcare industry. Alebund Pharmaceuticals is engaged in the research and development of new treatments for kidney disease and its complications and other chronic diseases. It has established a new drug product pipeline for kidney disease, including products for chronic kidney disease (CKD)/dialysis complications, IgA nephropathy, diabetic nephropathy, focal segmental glomerulosclerosis (FSGS), autosomal dominant polycystic kidney disease (ADPKD), etc. The company generates revenue by developing new renal drug products targeting chronic kidney disease (CKD)/dialysis complications.
Who invested in Alebund Pharmaceuticals
15 investors across 4 rounds
See all investors in Alebund Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alebund Pharmaceuticals
Who invested in Alebund Pharmaceuticals?
Alebund Pharmaceuticals has 15 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alebund Pharmaceuticals raised?
Alebund Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Alebund Pharmaceuticals last raise money?
Alebund Pharmaceuticals's most recent round on record is a Series C, in Jan 2025.
What does Alebund Pharmaceuticals do?
Established in 2018 and based in Shanghai, China, Alebund Pharmaceuticals is a biopharmaceutical company that engages in the research and development of drugs for kidney diseases and related chronic diseases.
Where is Alebund Pharmaceuticals headquartered?
Alebund Pharmaceuticals is headquartered in Shanghai, China.
Which VCs invest in companies like Alebund Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Alebund Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Alebund Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.